Vimarsana
Biggest News Aggregation in the World

Page 6 - Upfront Payment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Upfront Payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Upfront Payment Today - Breaking & Trending Today

Coal ministry transfers Rs 704 crore upfront payment to 6 coal-bearing states - Vimarsana News

Coal ministry transfers Rs 704 crore upfront payment to 6 coal-bearing states

"The Ministry of Coal has transferred Rs 704 crore upfront amount received from auction of coal mines to these six coal-bearing states. This financial transfer marks a substantial initiative to empower and support developmental growth of these states," Ministry of Coal statement said.

ISC Adds New Lender to Syndicated Credit Facility - Vimarsana News

ISC Adds New Lender to Syndicated Credit Facility

REGINA, Saskatchewan, July 27, 2023 -- Information Services Corporation announced today that it has expanded the lenders under the Company’s secured syndicated credit facility to include the...

Noida Authority to auction Sector 43 group housing plot next month; top builders, including Birlas, in queue - Vimarsana News

Noida Authority to auction Sector 43 group housing plot next month; top builders, including Birlas, in queue

However, the auction of another group housing plot in Sector 44 may take time as not enough bids have been received for that plot.

Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation - Vimarsana News

Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation

Travere Therapeutics Inc (NASDAQ: TVTX) has agreed to sell its bile acid product portfolio that, which includes Cholbam (cholic acid) and Chenodal (chenodiol), two medications, to Mirum Pharmaceuticals Inc (NASDAQ: MIRM). Mirum will purchase Travere's bile acid product portfolio for up to $445 million, consisting of $210 million upfront and $235 million in potential sales-based milestone payments. Mirum will acquire Travere's rights to Cholbam, indicated for bile acid synthesis disorders due to

Source: yahoo.com
ISC Secures Saskatchewan Registries Extension Until 2053 - Vimarsana News

ISC Secures Saskatchewan Registries Extension Until 2053

Extends a long-standing and successful public-private partnership until 2053 and re-affirms ISC's position as one of Canada's leading registry operatorsUnlocks value of the Saskatchewan Registries - a high-quality